Cigna Group

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $39.8b $41.8b $48.6b $153.6b $160.4b $174.1b $180.5b $195.3b $247.1b $274.9b
Revenues:
Cost of Revenue $36.8b $2.5b $4.8b $97.7b $103.5b $117.6b $124.8b $133.8b $182.5b $215.0b
Gross Profit (Calculated) $3.1b $39.4b $43.9b $55.9b $56.9b $56.5b $55.7b $61.5b $64.6b $59.9b
Operating Income (Loss) $3.1b $3.9b $4.2b $8.1b $8.2b $7.9b $8.4b $8.5b $9.4b $9.2b
Additional Financial Items
Amortization of Intangible Assets $151.0m $115.0m $235.0m $2.9b $2.0b $2.0b $1.9b $1.8b $1.7b $1.7b
Amortization of acquired intangible assets $151.0m $115.0m $235.0m $2.9b $2.0b $2.0b $1.9b $1.8b $1.7b $1.7b
Debt extinguishment gain $0 ($321.0m) $0 ($2.0m) ($199.0m) ($141.0m) $0 $0
Net gain (loss) on sale of businesses $0 $0 $4.2b $0 $1.7b ($1.5b) $24.0m $13.0m
Net investment losses ($487.0m) ($78.0m) ($2.7b) ($24.0m)
Premiums $30.8b $32.5b $36.1b $39.7b $42.6b $41.2b $39.9b $44.2b $46.0b $40.3b
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3.0b $3.6b $3.6b $6.6b $10.9b $6.8b $8.4b $5.5b $5.3b $7.8b
Net Investment Income $1.1b $1.2b $1.5b $1.4b $1.2b $1.5b $1.2b $1.2b $973.0m $1.0b
Policyholder Benefits and Claims Incurred, Net $24.3b $25.3b $27.5b $30.8b $32.7b $33.6b $32.2b $36.3b $38.6b $34.3b
Premiums Earned, Net $30.8b $32.5b $36.1b $39.7b $42.6b $41.2b $39.9b $44.2b $46.0b $40.3b
TOTAL INCOME TAXES $1.1b $1.4b $935.0m $1.4b $2.4b $1.4b $1.6b $141.0m $1.5b $1.5b
Income before income taxes $3.0b $3.6b $3.6b $6.6b $10.9b $6.8b $8.4b $5.5b $5.3b $7.8b
SHAREHOLDERS' NET INCOME $1.9b $2.2b $2.6b $5.1b $8.5b $5.4b $6.7b $5.2b $3.4b $6.0b
Net Income (Loss) Attributable to Parent $1.8b $2.2b $2.6b $5.1b $8.5b $5.4b $6.7b $5.4b $3.8b $6.0b
Net Income (Loss) Available to Common Stockholders, Basic $1.8b $2.2b $2.6b $5.1b $8.5b $5.4b $6.7b $5.2b $3.4b $6.3b
Less: Net income attributable to noncontrolling interests ($24.0m) ($5.0m) $9.0m $16.0m $31.0m $50.0m $78.0m $208.0m $344.0m $331.0m
Net Income (Loss) Attributable to Noncontrolling Interest ($24.0m) ($5.0m) $9.0m $16.0m $31.0m $50.0m $78.0m $208.0m $344.0m $331.0m
Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest ($5.0m) $0 $5.0m $17.0m $31.0m $67.0m $28.0m $344.0m $331.0m
Common Stock, Dividends, Per Share, Declared $7.31 $8.92 $10.69 $0.04 $0.04 $4.00 $4.48 $4.92 $5.60 $6.04
Earnings Per Share, Basic $7.31 $8.92 $10.69 $13.58 $23.17 $15.87 $21.54 $17.57 $12.25 $22.33
Earnings Per Share, Diluted $7.19 $8.77 $10.54 $13.44 $22.96 $15.73 $21.30 $17.39 $12.12 $22.18
Weighted Average Number of Shares Outstanding, Diluted 255.1m 250.2m 379.8m 368.4m 341.0m 313.1m 296.9m 283.2m 268.6m
Expenses
Current Income Tax Expense (Benefit) $1.1b $1.0b $1.8b $2.8b $1.6b $2.1b $1.8b $1.6b $1.2b
Deferred Policy Acquisition Costs, Amortization Expense $322.0m $406.0m $483.0m $502.0m $478.0m $319.0m
Interest Expense, Debt $243.0m $507.0m $1.6b $1.4b $1.3b $1.3b $1.4b $1.5b $1.4b
Interest expense and other ($278.0m) ($252.0m) ($498.0m) ($1.7b) ($1.4b) ($1.2b) ($1.2b) ($1.4b) ($1.4b) ($1.4b)
Medical costs and other benefit expenses $24.3b $25.3b $27.5b $30.8b $32.7b $33.6b $32.2b $36.3b $38.6b $34.3b
Other Nonoperating Income (Expense) ($278.0m) ($252.0m) ($498.0m) ($1.7b) ($1.4b) ($1.2b) ($1.2b) ($1.4b) ($1.4b) ($1.4b)
Pharmacy and other service costs $2.5b $2.5b $4.8b $97.7b $103.5b $117.6b $124.8b $133.8b $182.5b $215.0b
Selling, General and Administrative Expense $9.8b $10.0b $11.9b $14.1b $14.1b $13.0b $13.2b $14.8b $14.8b $14.6b
Selling, general and administrative expenses $9.8b $10.0b $11.9b $14.1b $14.1b $13.0b $13.2b $14.8b $14.8b $14.6b
Benefits, Losses and Expenses $36.8b $37.9b $44.5b $145.5b $152.2b $166.1b $172.1b $186.7b $237.7b $265.7b
Income Tax Expense (Benefit) $1.1b $1.4b $935.0m $1.4b $2.4b $1.4b $1.6b $141.0m $1.5b $1.5b
TOTAL BENEFITS AND EXPENSES $36.8b $37.9b $44.5b $145.5b $152.2b $166.1b $172.1b $186.7b $237.7b $265.7b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.